Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Giorgio Gargari is active.

Publication


Featured researches published by Giorgio Gargari.


Cell Reports | 2017

T Follicular Helper Cells Promote a Beneficial Gut Ecosystem for Host Metabolic Homeostasis by sensing Microbiota-Derived Extracellular ATP.

Lisa Perruzza; Giorgio Gargari; Michele Proietti; Bruno Fosso; Anna Maria D’Erchia; Caterina Elisa Faliti; Tanja Rezzonico-Jost; Daniela Scribano; Laura Mauri; Diego Colombo; Giovanni Pellegrini; Annalisa Moregola; Catherine Mooser; Mauro Nicoletti; Giuseppe Danilo Norata; Markus B. Geuking; Kathy D. McCoy; Simone Guglielmetti; Fabio Grassi

Summary The ATP-gated ionotropic P2X7 receptor regulates T follicular helper (Tfh) cell abundance in the Peyer’s patches (PPs) of the small intestine; deletion of P2rx7, encoding for P2X7, in Tfh cells results in enhanced IgA secretion and binding to commensal bacteria. Here, we show that Tfh cell activity is important for generating a diverse bacterial community in the gut and that sensing of microbiota-derived extracellular ATP via P2X7 promotes the generation of a proficient gut ecosystem for metabolic homeostasis. The results of this study indicate that Tfh cells play a role in host-microbiota mutualism beyond protecting the intestinal mucosa by induction of affinity-matured IgA and suggest that extracellular ATP constitutes an inter-kingdom signaling molecule important for selecting a beneficial microbial community for the host via P2X7-mediated regulation of B cell help.


Applied and Environmental Microbiology | 2016

Consumption of a Bifidobacterium bifidum Strain for 4 Weeks Modulates Dominant Intestinal Bacterial Taxa and Fecal Butyrate in Healthy Adults

Giorgio Gargari; Valentina Taverniti; Silvia Balzaretti; Chiara Ferrario; Claudio Gardana; Paolo Simonetti; Simone Guglielmetti

ABSTRACT Modulation of the intestinal microbial ecosystem (IME) is a useful target to establish probiotic efficacy in a healthy population. We conducted a randomized, double-blind, crossover, and placebo-controlled intervention study to determine the impact of Bifidobacterium bifidum strain Bb on the IME of adult healthy volunteers of both sexes. High-throughput 16S rRNA gene sequencing was used to characterize the fecal microbiota before and after 4 weeks of daily probiotic cell consumption. The intake of approximately one billion live B. bifidum cells affected the relative abundance of dominant taxa in the fecal microbiota and modulated fecal butyrate levels. Specifically, Prevotellaceae (P = 0.041) and Prevotella (P = 0.034) were significantly decreased, whereas Ruminococcaceae (P = 0.039) and Rikenellaceae (P = 0.010) were significantly increased. We also observed that the probiotic intervention modulated the fecal concentrations of butyrate in a manner dependent on the initial levels of short-chain fatty acids (SCFAs). In conclusion, our study demonstrates that a single daily administration of Bifidobacterium bifidum strain Bb can significantly modify the IME in healthy (not diseased) adults. These findings demonstrate the need to reassess the notion that probiotics do not influence the complex and stable IME of a healthy individual. IMPORTANCE Foods and supplements claimed to contain health-promoting probiotic microorganisms are everywhere these days and mainly intended for consumption by healthy people. However, it is still debated what actual effects probiotic products may have on the healthy population. In this study, we report the results of an intervention trial aimed at assessing the modifications induced in the intestinal microbial ecosystem of healthy adults from the consumption of a probiotic product. Our results demonstrate that the introduction of a probiotic product in the dietary habits of healthy people may significantly modify dominant taxa of the intestinal microbiota, resulting in the modulation of short-chain fatty acid concentrations in the gut. The overall changes witnessed in the probiotic intervention indicate a mechanism of microbiota modulation that could have potential effects on human health.


Frontiers in Microbiology | 2017

Viromes As Genetic Reservoir for the Microbial Communities in Aquatic Environments: A Focus on Antimicrobial-Resistance Genes

Stefano Colombo; Stefania Arioli; Eros Neri; Giulia Della Scala; Giorgio Gargari; Diego Mora

Despite studies of viromes isolated from aquatic environments are becoming increasingly frequent, most of them are limited to the characterization of viral taxonomy. Bacterial reads in viromes are abundant but the extent to which this genetic material is playing a role in the ecology of aquatic microbiology remains unclear. To this aim, we developed of a useful approach for the characterization of viral and microbial communities of aquatic environments with a particular focus on the identification of microbial genes harbored in the viromes. Virus-like particles were isolated from water samples collected across the Lambro River, from the spring to the high urbanized Milan area. The derived viromes were analyzed by shotgun metagenomic sequencing looking for the presence, relative abundance of bacterial genes with particular focus on those genes involved in antimicrobial resistance mechanisms. Antibiotic and heavy metal resistance genes have been identified in all virome samples together with a high abundance of reads assigned to cellular processes and signaling. Virome data compared to those identified in the microbiome isolated from the same sample revealed differences in terms of functional categories and their relative abundance. To verify the role of aquatic viral population in bacterial gene transfer, water-based mesocosms were perturbed or not perturbed with a low dose of tetracycline. The results obtained by qPCR assays revealed variation in abundance of tet genes in the virome and microbiome highlighting a relevant role of viral populations in microbial gene mobilization.


United European gastroenterology journal | 2018

Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial:

Cesare Cremon; Simone Guglielmetti; Giorgio Gargari; Valentina Taverniti; Anna Maria Castellazzi; Chiara Valsecchi; Carlotta Tagliacarne; Walter Fiore; M. Bellini; Lorenzo Bertani; Dario Gambaccini; Michele Cicala; B. Germanà; Maurizio Vecchi; Isabella Pagano; Maria Raffaella Barbaro; Vincenzo Stanghellini; Giovanni Barbara

Background Evidence suggests a role of intestinal microbiota-host interactions in the pathophysiology and symptoms of irritable bowel syndrome (IBS). Objective The objective of this article is to assess the effects of Lactobacillus paracasei CNCM I-1572 on clinical and gut microbiota-related factors in IBS. Methods We conducted a multicenter, randomized, double-blind, cross-over, 18-week, placebo-controlled, pilot trial assessing the effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota composition, fecal short chain fatty acid (SCFA), immunoglobulin A, and cytokines in IBS. The intestinal microbial ecosystem was characterized by 16S rRNA gene profiling. Results Forty IBS patients were enrolled from five Italian centers. Lactobacillus paracasei CNCM I-1572 did not significantly improve IBS symptoms, including primary efficacy variables worst abdominal pain/discomfort and IBS degree of relief. Interestingly, Lactobacillus paracasei CNCM I-1572 induced a significant reduction in genus Ruminococcus, dominated by taxa related to Ruminococcus bromii and Ruminococcus callidus, a significant increase in the SCFAs acetate and butyrate, and a significant reduction in the pro-inflammatory cytokine interleukin-15. Conclusions This pilot study shows that Lactobacillus paracasei CNCM I-1572 is able to modulate gut microbiota structure/function and reduce immune activation in IBS. As no statistically significant effect on IBS-symptoms was found, further studies are necessary to determine the role of this probiotic in IBS. The study was registered at ClinicalTrials.gov registry under identifier NCT02371499.


International Journal of Food Sciences and Nutrition | 2017

Serum lipid profile and fatty acid composition of erythrocyte phospholipids in children and adolescents with primary hyperlipidemia

Valeria Deon; Cristian Del Bo; Federica Guaraldi; Giorgio Gargari; Andrea Bosusco; Paolo Simonetti; Patrizia Riso; Ornella Guardamagna

Abstract This study aimed at characterizing the fatty acid (FA) composition of red blood cell (RBC) phospholipids in children and adolescents with primary hyperlipidemia, and to ascertain potential association with serum lipid profile and dietary factors. At this purpose, 54 probands aged 6–17 years were recruited. Subjects showed a low omega-3 index (eicosapentaenoic acid, EPA + docosahexaenoic acid, DHA <4%). Compared to males, females had a trend toward lower levels of total monounsaturated fatty acids (MUFA) and MUFA/saturated fatty acids (SFAs) ratio in RBCs. An inverse relationship between MUFA concentration in RBCs and serum cholesterol or HDL-C/triglycerides ratio was found. Omega-6 polyunsaturated fatty acids (n-6 PUFA) were positively associated to serum HDL-C levels, and inversely to dietary cholesterol. Fiber intake was positively associated with MUFA/SFA ratio. In conclusion, we provide the first experimental data on phospholipid FA composition of RBCs in hyperlipidemic children, showing sex differences and an overall low omega 3-index.


Environmental Microbiology | 2018

Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome: Fecal microbial ecosystem of IBS subtypes

Giorgio Gargari; Valentina Taverniti; Claudio Gardana; Cesare Cremon; Filippo Canducci; Isabella Pagano; Maria Raffaella Barbaro; Anna Maria Castellazzi; Chiara Valsecchi; Sara Carlotta Tagliacarne; M. Bellini; Lorenzo Bertani; Dario Gambaccini; Santino Marchi; Michele Cicala; B. Germanà; Elisabetta Dal Pont; Maurizio Vecchi; Cristina Ogliari; Walter Fiore; Vincenzo Stanghellini; Giovanni Barbara; Simone Guglielmetti

Irritable bowel syndrome (IBS), a common functional gastrointestinal disorder, is classified according to bowel habits as IBS with constipation (IBS-C), with diarrhea (IBS-D), with alternating constipation and diarrhea (IBS-M), and unsubtyped (IBS-U). The mechanisms leading to the different IBS forms are mostly unknown. This study aims to evaluate whether specific fecal bacterial taxa and/or short-chain fatty acids (SCFAs) can be used to distinguish IBS subtypes and are relevant for explaining the clinical differences between IBS subcategories. We characterized five fecal samples collected at 4-weeks intervals from 40 IBS patients by 16S rRNA gene profiling and SCFA quantification. Finally, we investigated the potential correlations in IBS subtypes between the fecal microbial signatures and host physiological and clinical parameters. We found significant differences in the distribution of Clostridiales OTUs among IBS subtypes and reduced levels of SCFAs in IBS-C compared to IBS-U and IBS-D patients. Correlation analyses showed that the diverse representation of Clostridiales OTUs between IBS subtypes was associated with altered levels of SCFAs; furthermore, the same OTUs and SCFAs were associated with the fecal cytokine levels and stool consistency. Our results suggest that intestinal Clostridiales and SCFAs might serve as potential mechanistic biomarkers of IBS subtypes and represent therapeutic targets.


Journal of Applied Microbiology | 2018

Characterization of airborne viromes in cheese production plants

Stefano Colombo; Stefania Arioli; Giorgio Gargari; E. Neri; G. Della Scala; Diego Mora

To characterize airborne virus‐like particles isolated from two cheese production plants in order to reveal their complexity in terms of viral communities and microbial genes potentially mobilized by viruses.


Environmental Microbiology | 2016

Evidence of a bacterial core in the stored products pest Plodia interpunctella: the influence of different diets

Matteo Montagna; Valeria Mereghetti; Giorgio Gargari; Simone Guglielmetti; Franco Faoro; Giuseppe Carlo Lozzia; Daria Patrizia Locatelli; Lidia Limonta


Gastroenterology | 2018

Su1660 - The Fecal Microbial Ecosystem in Irritable Bowel Syndrome is Distinct According to Bowel Habit Characteristics

Cesare Cremon; Simone Guglielmetti; Giorgio Gargari; Valentina Taverniti; Walter Fiore; M. Bellini; Michele Cicala; B. Germanà; Maurizio Vecchi; M. Raffaella Barbaro; Rosanna Cogliandro; Eleonora Capelli; Vincenzo Stanghellini; Giovanni Barbara


FEMS Microbiology Ecology | 2018

Evidence of dysbiosis in the intestinal microbial ecosystem of children and adolescents with primary hyperlipidemia and the potential role of regular hazelnut intake

Giorgio Gargari; Valeria Deon; Valentina Taverniti; Claudio Gardana; Marco Denina; Patrizia Riso; Ornella Guardamagna; Simone Guglielmetti

Collaboration


Dive into the Giorgio Gargari's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michele Cicala

Sapienza University of Rome

View shared research outputs
Researchain Logo
Decentralizing Knowledge